We are looking for young people at least 2 years of age but under 18 to join a CD research study to help us discover more about treating Crohn’s disease. If you are looking for a potential new treatment option for Crohn’s disease or Crohn’s (including associated symptoms such as recurrent diarrhea, iron deficiency, cramps, chronic fatigue and/or canker sores), consider one of our IBD clinical trials. All eligible participants will receive no-cost study-related care and study medication. Your young people at least 2 years of age but under 18 may be eligible to take part.

Your child may be eligible to take part in the IBD clinical trials if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Enrollment is limited so act quickly.

Is your child currently experiencing moderately to severely active IBD flare-ups? Local CD trial is testing a potential new medication to see if it may reduce rectal bleeding, diarrhea, abdominal pain, chronic fatigue, and/or anemia associated with moderately to severely active IBD.
If you’re concerned about how moderately to severely active IBD affects your child’s life, find out more about the CD trial.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Enrolling for a limited time.

We are looking for children and teenagers 2–17 years of age to join a Crohn’s disease clinical research to help us discover more about treating Crohn’s. If you are looking for a potential new treatment option for Crohn’s or gastrointestinal disease (including associated symptoms such as urgency to defecate, diarrhea, constant need to poop, weight loss and/or canker sores), consider one of our GI clinical research studies. All eligible participants will receive no-cost study-related care and study medication. Your children and teenagers 2–17 years of age may be eligible to take part.

Your child may be eligible to take part in the GI clinical research studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Enrolling for a limited time.

Is your child currently experiencing moderate to severe UC flare-ups? Local Crohn’s disease clinical research study is testing a potential new medication to see if it may reduce bloody diarrhea, diarrhea, diarrhea, frequent fevers, and/or eye pain associated with moderate to severe UC.
If you’re concerned about how moderate to severe UC affects your child’s life, find out more about the Crohn’s disease clinical research study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Find out if your child is eligible.

We are looking for young people 2–17 years old to join a clinical research to help us discover more about treating IBD. If you are looking for a potential new treatment option for IBD or moderate to severe IBD (including associated symptoms such as bloody diarrhea, loss of appetite, abdominal pain, chronic fatigue and/or eye pain), consider one of our GI clinical trials. All eligible participants will receive no-cost study-related care and study medication. Your young people 2–17 years old may be eligible to take part.

Your child may be eligible to take part in the GI clinical trials if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Find out if your child is eligible.

Is your child currently experiencing Crohn’s flare-ups? Local CD clinical research is testing a potential new medication to see if it may reduce tiredness, fistula, abdominal pain, malnutrition, and/or canker sores associated with Crohn’s.
If you’re concerned about how Crohn’s affects your child’s life, find out more about the CD clinical research.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Find out if your child is eligible.

We are looking for children and teenagers 2–17 years of age to join a CD study to help us discover more about treating ulcerative colitis. If you are looking for a potential new treatment option for ulcerative colitis or moderate to severe Crohn’s disease (including associated symptoms such as diarrhea with blood and pus, mouth sores, constant need to poop, frequent fevers and/or canker sores), consider one of our clinical research. All eligible participants will receive no-cost study-related care and study medication. Your children and teenagers 2–17 years of age may be eligible to take part.

Your child may be eligible to take part in the clinical research if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Find out if your child is eligible.

Is your child currently experiencing CD and UC flare-ups? Local Crohn’s disease (CD) research is testing a potential new medication to see if it may reduce stomach pain, growth failure, bloody stool, weight loss, and/or canker sores associated with CD and UC.
If you’re concerned about how CD and UC affects your child’s life, find out more about the Crohn’s disease (CD) research.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Enrolling for a limited time.

We are looking for children 2 to 17 years of age to join a trial to help us discover more about treating moderately to severely active IBD. If you are looking for a potential new treatment option for moderately to severely active IBD or moderate to severe ulcerative colitis (including associated symptoms such as diarrhea, unexplained weight loss, cramps, malnutrition and/or liver disease), consider one of our GI clinical research studies. All eligible participants will receive no-cost study-related care and study medication. Your children 2 to 17 years of age may be eligible to take part.

Your child may be eligible to take part in the GI clinical research studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Enrolling for a limited time.

Is your child currently experiencing moderate to severe IBD flare-ups? Local CD study is testing a potential new medication to see if it may reduce chronic diarrhea, inflammation of the bowel or intestine, rectal pain, frequent fevers, and/or eye pain associated with moderate to severe IBD.
If you’re concerned about how moderate to severe IBD affects your child’s life, find out more about the CD study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Find out if your child qualifies.